PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27846195-9	2017	CONCLUSION: Genetic variations in the ADCK1 gene may differentially predict paliperidone efficacy in schizophrenic patients.	Paliperidone Palmitate	76-88	aarF domain containing kinase 1	Homo sapiens	38-43	
30426252-0	2019	Genetic variations in the ADCK1 gene predict paliperidone palmitate efficacy in Han Chinese patients with schizophrenia.	Paliperidone Palmitate	45-67	aarF domain containing kinase 1	Homo sapiens	26-31	
30426252-1	2019	Genome-wide association study results have linked ADCK1 genetic variation with paliperidone efficacy in a European cohort.	Paliperidone Palmitate	79-91	aarF domain containing kinase 1	Homo sapiens	50-55	
30426252-4	2019	Examination of 13 ADCK1 genetic variants revealed two single nucleotide polymorphisms (rs12590199, rs11159291) and one haplotype (rs2364747-rs12590199) associated with paliperidone palmitate response.	Paliperidone Palmitate	168-190	aarF domain containing kinase 1	Homo sapiens	18-23	
30426252-5	2019	Future work into ADCK1"s function and its potential interaction with paliperidone is warranted.	Paliperidone Palmitate	69-81	aarF domain containing kinase 1	Homo sapiens	17-22